Maven Copy Trading Rules: Own Accounts and EA Restrictions

Maven’s current FAQ prohibits copying another individual’s trades and prohibits EAs on all its platforms. The FAQ reviewed on September 30, 2026 does not provide the blanket own-account automated-copier approval previously described on this page. Do not treat account ownership alone as confirmation that Copygram is permitted. Read Maven’s official FAQ.

This independent guide distinguishes technical compatibility from firm permission and gives you a short checklist for resolving the question before spending money on a connection.

Does Maven allow a trade copier between your own accounts?

The public FAQ reviewed does not settle approval of the exact Copygram workflow. Our recommendation is to obtain written confirmation covering the product, source, receiver and order-generation method. This is an unresolved permission question, not a statement that every own-account copier is banned.

Avoid relying on a third-party review that says “own accounts are allowed” without identifying a current official rule. Save the answer and the applicable account agreement so you can compare them when the program or setup changes.

What to include in your request to Maven

• Your exact challenge product, account stage and trading platform.

• The name Copygram and the connection method you intend to use.

• Who owns and controls the source and each receiver.

• Whether you manually make trading decisions or software generates orders.

• Whether the connection changes volume, symbols, stops or exits.

• Whether an external broker or another prop firm is part of the route.

Ask for a response to the complete arrangement. An answer about holding several accounts, or about manually trading an account, does not necessarily answer the separate question about software submitting orders.

Does owning multiple Maven accounts answer the copying question?

No. Maven’s FAQ describes a funded starting-capital limit of $200,000, but an allocation allowance is separate from automation permission. Check your product’s terms and any scaling rules directly with the firm. Maven’s account limits and trading rules.

For your own planning, list the accounts and their current restrictions separately. Account size, platform access and copying permission are three different facts; confirming one does not establish the others.

What Copygram supports technically

Copygram supports MT5 and MatchTrader as receivers. That establishes a platform capability; it does not establish Maven’s approval of the software, its cloud connection or a particular strategy. Copygram does not currently support cTrader as a sender or receiver.

If Maven confirms your proposed route, compare the exact account connection with the Copygram documentation. The MetaTrader-to-MatchTrader overview explains that supported platform route. It should not be read as an authorization to use it with every firm offering MatchTrader.

Check receiver behavior before relying on it

After permission and connection support are resolved, use a permitted practice environment to check the whole order lifecycle. Compare entries, stop changes, cancellations and exits in both platforms. Confirm symbol specifications and quantity settings instead of assuming that similarly named instruments behave identically.

Keep a record of rejected orders and decide how to reconcile a receiver that becomes disconnected. A successful login or one copied entry is not a complete test of the setup.

Copygram’s documented sizing settings do not guarantee compliance with a firm’s drawdown rules. Several open trades, execution differences and costs can affect the result. The prop-firm account checklist covers these operational checks in more detail.

Before purchasing

Do not purchase Copygram specifically for Maven until the permission and connection questions are resolved. If the workflow is confirmed, review the current paid plans and account limits. Copygram offers no free trial, and a copying subscription does not guarantee that a challenge will be passed or a payout approved.